CD69 has been identified as a B cell marker associated with MS (64) whereas CD80 and CD86 are costimulatory molecules that are involved in immune regulation and B cells expressing CD80/CD86 have been shown to drive pathogenesis in autoimmunity (65, 66). This evidence concerns the gene CD80 and myeloid sarcoma.